Biosimilar Uptake Gains Momentum In The US
Payer And Provider Strategies To Encourage Uptake Are Gaining Traction
Getting doctors to prescribe lower cost biologics has become less of a challenge as additional products reach the market in the US, according to panelists at the World Biosimilar Congress.
